THE MANAGEMENT of plaque psoriasis has evolved significantly over the past two decades, with biologic treatments becoming ...

Studies involving multiple aspects of plaque psoriasis evolution, persistence, and progression have produced clues and ...

The following is a summary of “Bimekizumab durability of efficacy through 196 weeks and safety through 4 years in patients ...

Uncover the reasons for crustiness behind ears, alongside symptoms, and how dry skin, psoriasis, and infections contribute to ...

Reviewed by Dietitian Annie Nguyen, M.A., RD A new study connects ultra-processed foods with an increased risk of developing ...

A real-world study finds elderly psoriasis patients treated with IL-17 and IL-23 inhibitors achieve comparable long-term ...

Living with psoriasis presents unique challenges, but with the right skincare routine, you can maintain healthy skin.

George Warren, PhD, Lead Author and Principal Scientist at Artelo, said, "We are excited to share the results on this novel ...

ART26.12 has a unique pharmacology with lower toxicological risks and aims to provide a safer, non-opioid treatment alternative. Psoriasis treatments can be effective but often have significant ...

The results of an open-label extension study confirmed the interchangeability of biosimilar CT-917 with reference adalimumab for plaque psoriasis.

People with acne are at increased risk of developing an eating disorder, a new study says. Adult acne patients are 2.4 times ...

Artelo Biosciences advances ART26.12 for psoriasis and CIPN, while ART27.13 shows early promise in cancer-related anorexia ...